•
Sep 30, 2021

Halozyme Q3 2021 Earnings Report

Total Revenue
$116M
Previous year: $65.3M
+77.3%
EPS
$0.55
Previous year: $0.25
+120.0%
Gross Profit
$97.2M
Previous year: $3.48M
+2694.3%
Cash and Equivalents
$492M
Previous year: $65.7M
+647.9%
Free Cash Flow
$121M
Previous year: $5.91M
+1952.2%
Total Assets
$1.19B
Previous year: $524M
+126.2%

Halozyme

Halozyme

Halozyme Revenue by Segment